AMS Group reports ‘strong’ first half amid rumoured takeover interest healthcare In the six months to June, revenue rose by eight per cent to £68.0m, with strong growth in the firm's surgical business unit offsetting "challenges" in its Woundcare unit.
Hikma given shot in the arm by ‘excellent’ double-digit growth Business Pharmaceutical firm Hikma has hiked its dividend and raised its guidance having hailed an “excellent” first half of the year. The Jordanian-founded FTSE 100 pharma firm, which in June bolstered its injectables offering with the purchase of Danish rival Xellia, posted a double-digit revenue rise of 10 per cent, raking in $1.6bn (£1.3bn) in the [...]
GSK wins latest Zantac trial as jury finds drug did not cause woman’s cancer pharma GSK - formerly GlaxoSmithKline - has won its latest trial over whether its most popular drug caused cancer on Monday, after a jury found it was not the root cause of an American woman's illness.
Eco Animal Health beats expectations thanks to Americas growth July 15, 2024 Animal vaccine firm Eco Animal Health beat earnings expectations despite continuing volatility in currency, thanks largely to its "robust" demand for its flagship vaccine and consistent market leading position.
Indivior shares plunge after US move and profit warning July 9, 2024 Indivior lowered its annual adjusted operating profit forecast and shares in the company plunged.
British Patient Capital invests £90m London biotech company July 8, 2024 British Patient Capital recently also invested £10m into biotech firm Curve Therapeutics to support its cancer drug discovery technology.
UK less ready for next pandemic than before Covid – Oxford vaccinologist July 3, 2024 The UK's state apparatus is less prepared to deal with a pandemic today than it was before Covid, one of the professors in charge of the Oxford Astrazeneca vaccine rollout has warned.
US drug giant Pfizer beats GSK to UK government contract for 4.9m vaccine shots June 25, 2024 Pfizer has beaten GSK to win a contract to supply millions of doses of a new respiratory vaccine in the UK after the government snubbed the local drugmaker.
Alliance Pharma sees profit and revenue spike amid ongoing uncertainty June 19, 2024 Alliance Pharma has hailed its strong second half performance for helping it to record sales and additional profit expansion in its preliminary results despite the healthcare group having delayed its audited results three times this year.
GSK: Good news for pharma giant as approval granted to expand vaccine use June 10, 2024 The FDA has expanded its approval of a GSK vaccine that prevents respiratory syncytial virus (RSV) to affect younger adults, in a move the company hopes will prevent thousands of hospitalisations each year.